Navigation Links
Cancer Doctors Okays Controversial Prostate Therapy

A controversial treatment for prostate cancer in which radioactive seeds are implanted in the prostate to destroy the tumor received support Friday from doctors writing therapy guidelines for the prestigious 17-hospital National Comprehensive Cancer Network (NCCN) meeting in Ft. Lauderdale, Fla. This type of therapy is known as brachytherapy, the procedure has been performed for years by researchers, but previous treatment guidelines for prostate cancer left the procedure out. "The weight of institutional experience at NCCN members allows us to expand the guidelines to include brachytherapy," said Dr. Howard Sandler, head of radiation therapy oncology at the University of Michigan Comprehensive Cancer Center one of the NCCN hospitals. Three years ago, when the NCCN produced its prostate cancer guidelines there was no mention of brachytherapy. "There was a lot of noise at the time about not putting brachytherapy in the guidelines," said Dr. Laurence Baker, associate chief of hematology/oncology at the University of Michigan and chairman of the committee writing the guidelines. The general consensus at the time, though, was that data on brachytherapy for prostate cancer still needed to mature before doctors were willing to consider it in the guidelines.
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Potential New Cancer Gene Identified
4. Consensus on "Combination Therapy" for Breast Cancer
5. Cancers of Colon & Rectum linked to Cigarette Smoking
6. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
7. The Cancer Rumour mill working over time
8. Cancer drugs in development nearly doubled since 1995
9. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
10. Cancer patients turning to Internet for information
11. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
Post Your Comments:
(Date:5/16/2008)...EWPORT BEACH, Calif., May 16 /PRNewswire-FirstCall...P ) announced today the promotion of David,M. Boit... Officer. "Dave,has made a tremendous contribution...y our strong investment growth and diversification... over $1 billion in accretive,investments for NHP,...
(Date:5/16/2008)...AN DIEGO, May 16 /PRNewswire-FirstCall/ -- CryoCor...cused on the treatment of cardiac,arrhythmias, ann...ers of,CryoCor common stock filed a complaint in t...ty of San Diego, naming as defendants each member ...Boston Scientific Corporation.,The complaint is st...
(Date:5/16/2008)...ment guidelines quickly disseminated to community ...16 (HealthDay News) -- Partnerships between major ...e a quick and effective way to spread cancer treat... Center in Philadelphia. , Most new cancer trea...ost cancer care is provided at community hospitals...
(Date:5/16/2008)...ismatch in some early stage cases makes therapy of...RIDAY, May 16 (HealthDay News) -- Colon cancer pat...need to receive chemotherapy. In fact, not only do..., it may actually harm them, a new study found. ,...ncer], then you should not be treated with chemoth...
Breaking Medicine News(10 mins):Health News:David M. Boitano Promoted to Senior Vice President 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4Health News:Partnerships Effective Communicators of Cancer Advances 2Health News:Not All Colon Cancer Patients Need Chemotherapy: Study 2
...eening system combining digital photography with I...method to screen for a common childhood oral disea...ty toddlers. Early childhood dental caries (ECC... tooth decay, results from prolonged exposure to s...
...study published in the journal, Cell Metabolism, r...ion in the zebrafish that are remarkably similar t...es disease that could aid in finding new therapies...ead to the aquarium fish becoming an important ani...
... mothers may someday get a personalized menu of fo...netic makeup as a result of new research at Washin... Researchers used transparent fish embryos to dev...genes and diet interact to cause birth defects. "...
...can children with asthma make more clinic visits t... severity.// Asthma has been on the rise for the ... especially high prevalence. A study in the August...hat Puerto Rican children with asthma make more cl...
Other Medicine News:Health News:New Screening System For Early Detection Of Dental Caries in Toddlers 2Health News:New Screening System For Early Detection Of Dental Caries in Toddlers 3Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 2Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 3Health News:New Studies On Zebrafish Could Aid in Treating Birth Defects 4Health News:Unmasking Nutrition's Role in Genes and Birth Defects 2Health News:Unmasking Nutrition's Role in Genes and Birth Defects 3Health News:Children of Different Race Show Different Patterns of Asthma Care 2
(Date:5/16/2008)...nd customer thought leaders -, SAN FRANCISCO, May...ader and trusted resource for clinical trial manag...prestigious academic medical centers, research,ins... group meeting in San,Francisco. The Velos eResear...boratively manage thousands of clinical trials., ...
(Date:5/16/2008)...r PEGylation of a Small Molecule with ...OS, Calif., May 16 /- Nekta...results today from a Phase 1,study of NKTR- 102, P...ti-tumor activity in patients with refractory soli...s small molecule PEGylation technology,produced an...
(Date:5/16/2008)... Significant Reductions in Selected ...ublished in 2008 Proceedings of the American Socie... SAN DIEGO, May 16 /- ADVE... today that, in a registrational bioequivalence,cl... significant reduction,in general disorders and ad...
(Date:5/15/2008)...FirstCall/ -- Medivation, Inc.,(Nasdaq: MDVN ) to...clinical,trial of its novel androgen receptor anta...entation at the 44th American Society of Clinical ...sion title: New Targeted Strategies for Patients w..., June 2 at 11:30 a.m. Central Time Abstract titl...
Breaking Medicine Technology:Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 2Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade 28TM 29 3260 1PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade 28TM 29 3260 2PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade 28TM 29 3260 3 2437 million financing for company based on macular degeneration research 3256 1 2437 million financing for company based on macular degeneration research 3256 2Lunch Lady Challenges Schools Families to Make Kids Nutrition a Priority 3251 1Lunch Lady Challenges Schools Families to Make Kids Nutrition a Priority 3251 2Angel Flight West Recognizes Southern California Pilots at 24th Anniversary 3246 1Angel Flight West Recognizes Southern California Pilots at 24th Anniversary 3246 2
Self retaining brain retractor.
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required.
Langenbeck periosteal elevators, wide, blade width 11/16" (17 mm), length 7 1/2" (191 mm).
Cushing periosteal elevators, Gutsch handle, sharp, narrow, blade width 3/16" (5 mm), length 7 5/8" (194 mm).
Medicine Products: